The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.

Siming ChenMengxue YuLingao JuGang WangKaiyu QianYu XiaoXing-Huan Wang

Published in: Cancer cell international (2021)

TEK plays an important role in risk assessment and survival prediction for ccRCC patients as a new immune gene and maybe an emerging target for immunotherapy for ccRCC patients.

Keyphrases

end stage renal disease
risk assessment
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
gene expression
signaling pathway
cell proliferation
genome wide
climate change
copy number
protein kinase